CloudMD Appoints Angel Paravicini as SVP, Business Development and Customer Success to Drive Expansion Across North America and Globally
Over 15 years’ executive sales leadership; Senior roles at LifeWorks and Teladoc Proven track record of building new distribution channels and penetrating new global markets Accelerate CloudMD’s momentum and expansion into the United States VANCOUVER, ... [Read]
CloudMD Reports Record Revenue of $15.7 Million in Second Quarter 2021; 9% Quarter Over Quarter Organic Growth
Record Q2 2021 revenue of $15.7 million; an increase of 461% compared to Q2 2020. Closed the acquisitions of Aspiria, Rxi, VisionPros and Oncidium in Q2 2021, adding $96 million of annual revenue. Launch of ... [Read]
CloudMD to Report Second Quarter Financial Results on August 25, 2021
VANCOUVER, British Columbia, Aug. 20, 2021 (GLOBE NEWSWIRE) — CloudMD Software & Services Inc. (TSXV:DOC)(OTCQB:DOCRF)(Frankfurt: 6PH)(the “Company” or “CloudMD”), a healthcare technology company revolutionizing the delivery of care, announces that it will report its second-quarter ... [Read]
CloudMD to Present at the Canaccord Genuity Growth Conference
VANCOUVER, British Columbia, Aug. 04, 2021 (GLOBE NEWSWIRE) — CloudMD Software & Services Inc. (TSXV:DOC)(OTCQB:DOCRF)(Frankfurt: 6PH) (the “Company” or “CloudMD”), a healthcare technology company revolutionizing the delivery of care, is pleased to announce that it ... [Read]
CloudMD Appoints Karen Adams as President and Provides Update on Oncidium Acquisition
Karen Adams is appointed President of the Company to deliver on growth strategy and operational effectiveness Dr. Amit Mathur is appointed to newly created leadership role, President, US Operations, to focus on expansion into the ... [Read]
CloudMD Closes Acquisition of Rxi, Providing an Established Specialty Drug Management and Patient Support Program to the Employer Market
VANCOUVER, British Columbia, May 12, 2021 (GLOBE NEWSWIRE) — CloudMD Software & Services Inc. (TSXV:DOC)(OTCQB:DOCRF)(Frankfurt: 6PH) (the “Company” or “CloudMD”), a healthcare technology company revolutionizing the delivery of care, is excited to announce that it has ... [Read]
CloudMD Reports Record Fourth Quarter 2020 Revenue; On Track for Significant Growth in 2021
Q4 2020 revenue of $5.8 million; up 138% compared to Q4 2019 and 73% compared to Q3 2020 Q4 2020 gross margin1 of over 40% attributable to strong revenue mix Strong balance sheet with current cash ... [Read]
CloudMD to Acquire Oncidium, One of the Largest Healthcare Providers to the Employer Market in Canada
Oncidium is one of Canada’s leading health management companies with a loyal client base of over 500 corporate and public sector clients across various industries This transformative acquisition expands CloudMD’s National footprint to include 5,500 ... [Read]
CloudMD to Participate in Upcoming Laurentian Bank and Bloom Burton and Co. Investor Conferences
VANCOUVER, British Columbia, April 05, 2021 (GLOBE NEWSWIRE) — CloudMD Software & Services Inc. (TSXV:DOC)(OTCQB:DOCRF)(Frankfurt: 6PH)(the “Company” or “CloudMD”), a healthcare technology company revolutionizing the delivery of care, is pleased to announce that the Company ... [Read]
CloudMD Announces Closing of IDYA4 Acquisition and North American Roll out of Substance Use Disorder Platform to Address Growing Addiction Crisis
The COVID-19 pandemic has resulted in a significant increase in substance use across North America IDYA4’s Real-Time Intervention Platform for Substance Use Disorder is used across 38 states in the United States The platform shares information ... [Read]